These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 24439736)
21. The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease. Zlotnick GW; Jones TR; Liberator P; Hao L; Harris S; McNeil LK; Zhu D; Perez J; Eiden J; Jansen KU; Anderson AS Hum Vaccin Immunother; 2015; 11(1):5-13. PubMed ID: 25483509 [TBL] [Abstract][Full Text] [Related]
22. Meningitis B vaccine to be introduced in UK after U turn on its cost effectiveness. Wise J BMJ; 2014 Mar; 348():g2327. PubMed ID: 24665138 [No Abstract] [Full Text] [Related]
23. Neisseria meningitidis B vaccines. Panatto D; Amicizia D; Lai PL; Gasparini R Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622 [TBL] [Abstract][Full Text] [Related]
24. Choosing a Mass Immunization Program against Meningococcal B. Wu K; Mulholland EK; Edwards KM N Engl J Med; 2020 Jan; 382(4):379-382. PubMed ID: 31971685 [No Abstract] [Full Text] [Related]
26. The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects. Mameli C; Galli E; Mantegazza C; Fabiano V; Zuccotti GV Future Microbiol; 2015; 10(10):1579-98. PubMed ID: 26437903 [TBL] [Abstract][Full Text] [Related]
27. [Group B meningococcal invasive infections: an unresolved public health problem]. Crisinel PA; Posfay-Barbe KM Rev Med Suisse; 2011 Feb; 7(283):447-50. PubMed ID: 21452513 [TBL] [Abstract][Full Text] [Related]
28. A case of meningococcal disease in a schoolgirl previously given meningococcal C vaccine. Pugh RN; Heseltine A Commun Dis Public Health; 2002 Mar; 5(1):74. PubMed ID: 12070983 [No Abstract] [Full Text] [Related]
29. Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation. Brehony C; Rodrigues CMC; Borrow R; Smith A; Cunney R; Moxon ER; Maiden MCJ Vaccine; 2016 Sep; 34(39):4690-4697. PubMed ID: 27521232 [TBL] [Abstract][Full Text] [Related]
30. Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB). Bettinger JA; Scheifele DW; Halperin SA; Vaudry W; Findlow J; Borrow R; Medini D; Tsang R; Vaccine; 2013 Dec; 32(1):124-30. PubMed ID: 23588089 [TBL] [Abstract][Full Text] [Related]
31. Challenges and progress in the development of a serogroup B meningococcal vaccine. Lewis S; Sadarangani M; Hoe JC; Pollard AJ Expert Rev Vaccines; 2009 Jun; 8(6):729-45. PubMed ID: 19485754 [TBL] [Abstract][Full Text] [Related]
32. Advances towards the prevention of meningococcal B disease: a multidimensional story. Roderick M; Finn A J Infect; 2014 Jan; 68 Suppl 1():S76-82. PubMed ID: 24139188 [TBL] [Abstract][Full Text] [Related]
33. Novel assessment of a novel meningitis B vaccine. Gill CJ Lancet Infect Dis; 2013 May; 13(5):381-2. PubMed ID: 23414710 [No Abstract] [Full Text] [Related]
34. Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016. Soeters HM; Dinitz-Sklar J; Kulkarni PA; MacNeil JR; McNamara LA; Zaremski E; Chang HY; Lujan E; Granoff D; Lasky M; Montana B Emerg Infect Dis; 2017 May; 23(5):867-869. PubMed ID: 28418307 [TBL] [Abstract][Full Text] [Related]
35. Impact of vaccination on meningococcal epidemiology. Stefanelli P; Rezza G Hum Vaccin Immunother; 2016 Apr; 12(4):1051-5. PubMed ID: 26512927 [TBL] [Abstract][Full Text] [Related]
36. Meningococcal serogroup B outbreaks and use of 4CMenB vaccine. Rose WE J Am Pharm Assoc (2003); 2014; 54(2):198-201. PubMed ID: 24632933 [No Abstract] [Full Text] [Related]